FDA applicant
Altaviz, LLC
FDA records 3 decisions for Altaviz, LLC (Irvine, CA) from 2022 to 2025: 3 510(k) clearances. Most are in product codes FMI (Needle, Hypodermic, Single Lumen) and QLY (Ophthalmic Syringe). Since 2016 its 510(k)s took a median of 90 days from receipt to decision, against 176 for FDA’s reviews in the same codes and years. Its devices cite 4 predicates, 1 of them its own earlier devices. 1 recall is linked to its devices.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Altaviz, LLC’s devices, and how often a recall has named them.
FDA decisions per year
1in 2025
2026 so far, outlined.
Recalls per year
1in 2023
Class I Class II/III not classified
Planning a device like Altaviz, LLC’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report